Landmark human insulin study marks 40-year anniversary

January 29, 2019 | Michael Easterling

In January 1979, the National Academy of Sciences published a paper about an innovative discovery at City of Hope that would forever change how diabetes is treated. Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., revolutionized diabetes treatment when they made a novel gene, one that coded for human insulin.

Continue Reading

City of Hope investigators present breakthrough research at 60th American Society of Hematology meeting

December 5, 2018 | Letisia Marquez

Physicians and researchers at the 2018 American Society of Hematology conference presented clinical trials for new leukemia and lymphoma treatments, laying the groundwork for innovative therapeutic approaches aimed at improving treatment options and quality of life for patients.

Larry Kwak, M.D., Ph.D., Receives Grant for Promising Lymphoma Work

January 12, 2018 | Letisia Marquez

Larry Kwak, M.D., Ph.D., received a grant to support his work with mantle cell lymphoma from the Leukemia & Lymphoma Society, the world’s largest voluntary health organization dedicated to fighting blood cancer.

Larry Kwak honored in Korea as recipient of prestigious Ho-Am Prize

July 5, 2016 | Letisia Marquez

City of Hope’s Larry Kwak, M.D., Ph.D., director of the Toni Stephenson Lymphoma Center, received well-deserved high honors when he traveled to Korea recently to receive the prestigious 2016 Ho-Am Prize in Medicine.

Targeting a cancer cell’s “master switch”

May 9, 2016 | City of Hope

According to a new study published in the prestigious scientific journal, Immunity, scientists at City of Hope have unlocked a key component of STAT3 activation, a gene that has long been associated with tumor cell growth and antitumor immune suppression. By exploring how STAT3 is activated in B cells, a major type of immune cell, our researchers have identified a novel target for cancer therapy.

Famed cancer researcher Larry W. Kwak receives Ho-Am award

April 20, 2016 | City of Hope

Renowned research scientist and physician Larry W. Kwak, M.D., Ph.D., who has previously been named by TIME magazine as one of the world’s 100 most influential people for his work in cancer immunotherapy, just added another major honor to his resume – the Ho-Am Prize in Medicine.

Avery Supplier Summit and Golf Outing Raises $200k for City of Hope

April 11, 2016 | City of Hope

Long-time National Business Products Industry member AVERY held their 2016 Supplier Summit and Golf Outing benefiting City of Hope February in Irvine, California.

Acclaimed physician Larry Kwak receives Korean American group award

January 22, 2016 | City of Hope

City of Hope’s Larry W. Kwak, M.D., is officially a hero. Kwak, the director of the Toni Stephenson Lymphoma Center at City of Hope, was honored by the Korean American Graduate Medical Association (KAGMA) earlier this month when the group gave him its first-ever Health Hero Award.